Medical News

RSS

TransPharma announces positive results of ViaDerm-hPTH Phase 1 trial for osteoporosis treatment

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a 4 week Phase 1 trial of its new self-applied ViaDerm-hPTH(1-34) for the treatment of osteoporosis.

26 Oct 2010

Shire receives Paragraph IV Notice Letter from Watson for INTUNIV tablet

Shire plc , the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter from Watson Laboratories, Inc. advising of the filing of an Abbreviated New Drug Application for a generic version of Shire's 4 mg guanfacine hydrochloride extended release tablet, INTUNIV.

26 Oct 2010

MiMedx third-quarter net loss decreases to $2.9 million

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today its results for the third quarter ended September 30, 2010.

26 Oct 2010

Bristol-Myers Squibb 2010 third quarter U.S. net sales increases 4% to $3.1 billion

Bristol-Myers Squibb Company today reported results for the third quarter of 2010. Highlights in the quarter included: the presentation of new data on investigational compounds in the diabetes and cardiovascular disease franchises at major medical meetings; the completion of important regulatory milestones in the oncology, diabetes and immunoscience franchises; the acquisition of ZymoGenetics; and double-digit EPS growth. The company also confirmed guidance for 2010.

26 Oct 2010

LCA-Vision third quarter net loss decreases to $8.4 million

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operational results for the three and nine months ended September 30, 2010.

26 Oct 2010

Techne Corporation 2011 first quarter net earnings decreases 1.5% to $26.4 million

Techne Corporation's consolidated net earnings for the quarter ended September 30, 2010 decreased 1.5% to $26.4 million or $.71 per diluted share compared with $26.8 million or $.72 per diluted share for the quarter ended September 30, 2009.

From BiosPacific, Inc. 26 Oct 2010

PURE Bioscience raises $2.376M through unregistered private placement

PURE Bioscience, creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it has sold $2.376 million of its common stock in an unregistered private placement solely to non-affiliated accredited investors.

26 Oct 2010

Racial disparities among children with frequent ear infections can influence access to health care resources

Ear infections are one of the most common health problems for children, with most kids experiencing at least one by their third birthday. Annual costs in the United States alone are in the billions of dollars.

26 Oct 2010

Compugen 2010 third quarter net loss decreases to $1.6 million from $1.9 million

Compugen Ltd. today reported financial results for the third quarter ending September 30, 2010.

26 Oct 2010

Amedisys 2010 third quarter Net service revenue increases 4.2% to $404.7 million

Amedisys, Inc. a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2010.

26 Oct 2010

First Edition: October 26, 2010

In today's headlines, more reports from the campaign trail -- highlighting how tempers and politics continue to flare around health overhaul issues.

26 Oct 2010

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

Biogen Idec Inc. a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its third quarter 2010 results.

26 Oct 2010

New findings could deliver low-cost method to extract anticancer compound

A popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests. Researchers have isolated and grown stem cells from a yew tree whose bark is a natural source of the anticancer compound paclitaxel. The development could enable the compound to be produced on a commercial scale at low cost, with no harmful by-products.

26 Oct 2010

India's Trade Minister says EU will take steps to prevent seizure of generic medicines

"India believes a row with the European Union over seizures of generic drugs will be settled without litigation, Trade Minister Anand Sharma said on Wednesday," Reuters reports (Lynn, 10/20).

26 Oct 2010

Archimedes launches AOA web application to help healthcare organizations

Archimedes Inc., a healthcare modeling company, announced today the launch of the Archimedes Outcomes Analyzer (AOA), a web application that expands access to data sets generated by the Archimedes Model, a large-scale simulation model that calculates clinical and cost outcomes, and answers complex healthcare questions.

26 Oct 2010

Kinetic Concepts 2010 third quarter total revenue increases 2% to $506.7 million

Kinetic Concepts, Inc. today reported third quarter 2010 total revenue of $506.7 million compared to $504.4 million in the third quarter of 2009 and up 2% from the second quarter of 2010.

26 Oct 2010

Einstein updates Strategic Research Plan

Albert Einstein College of Medicine of Yeshiva University has updated its Strategic Research Plan, the guidepost by which research priorities for the College of Medicine are set and measured. The update is designed to keep Einstein's research enterprise on course, to determine which investigative areas should be expanded or redirected, and to identify new areas that were underappreciated when the original research plan was formulated.

26 Oct 2010

Research indicates stroma tissue provides new drug target for treating pancreatic cancer

A project focusing on the scar tissue surrounding cancer tumours aims to provide new targets for drugs for treating pancreatic cancer, the fifth highest cause of cancer deaths in the UK.

26 Oct 2010

AAHC launches Education and Training Clinical Research Compliance Tool

The Association of Academic Health Centers (AAHC) launched the Education and Training Clinical Research Compliance Tool designed to assist academic health center leaders, research administrators, compliance and clinical trials office administrators, and directors of compliance education and training in strengthening and improving the development and implementation of clinical research compliance education and training programs.

26 Oct 2010

Biotage third quarter net sales increase 21% to 109.5 MSEK

Biotage: Third quarter 2010 Net sales increased by 21 % to 109.5 MSEK (90.6)

26 Oct 2010

Medical News

TransPharma announces positive results of ViaDerm-hPTH Phase 1 trial for osteoporosis treatment

Shire receives Paragraph IV Notice Letter from Watson for INTUNIV tablet

MiMedx third-quarter net loss decreases to $2.9 million

Bristol-Myers Squibb 2010 third quarter U.S. net sales increases 4% to $3.1 billion

LCA-Vision third quarter net loss decreases to $8.4 million

Techne Corporation 2011 first quarter net earnings decreases 1.5% to $26.4 million

PURE Bioscience raises $2.376M through unregistered private placement

Racial disparities among children with frequent ear infections can influence access to health care resources

Compugen 2010 third quarter net loss decreases to $1.6 million from $1.9 million

Amedisys 2010 third quarter Net service revenue increases 4.2% to $404.7 million

First Edition: October 26, 2010

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

New findings could deliver low-cost method to extract anticancer compound

India's Trade Minister says EU will take steps to prevent seizure of generic medicines

Archimedes launches AOA web application to help healthcare organizations

Kinetic Concepts 2010 third quarter total revenue increases 2% to $506.7 million

Einstein updates Strategic Research Plan

Research indicates stroma tissue provides new drug target for treating pancreatic cancer

AAHC launches Education and Training Clinical Research Compliance Tool

Biotage third quarter net sales increase 21% to 109.5 MSEK

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News